Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts.
about
Genetically modified human bone marrow derived mesenchymal stem cells for improving the outcome of human islet transplantationSurvival of encapsulated islets: More than a membrane storyRegenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem CellsClinical imaging in regenerative medicineIslet cell transplantation for the treatment of type 1 diabetes: recent advances and future challengesInhibition of inflammation and oxidative stress by an imidazopyridine derivative X22 prevents heart injury from obesityRole of the mitogen-activated protein kinases in cytokine-mediated inhibition of insulin gene expressionConcise Review: Macrophages: Versatile Gatekeepers During Pancreatic β-Cell Development, Injury, and Regeneration.Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation.Mesenchymal stem cells as a gene delivery vehicle for successful islet transplantation.Inflammatory response in islet transplantation.Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sitesAdipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia.Monitoring neovascularization of intraportal islet grafts by dynamic contrast enhanced magnetic resonance imaging.Biomolecular surface engineering of pancreatic islets with thrombomodulin.Presence of diabetes autoantigens in extracellular vesicles derived from human islets.Maternal protein malnutrition does not impair insulin secretion from pancreatic islets of offspring after transplantation into diabetic rats.Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines.Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancreatic islet endocrine cells.Enhancing human islet transplantation by localized release of trophic factors from PLG scaffolds.Combined small interfering RNA therapy and in vivo magnetic resonance imaging in islet transplantationThe therapeutic role of monocyte chemoattractant protein-1 in a renal tissue engineering strategy for diabetic patientsRNA interference for improving the outcome of islet transplantation.Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4/CD8 therapy.Thioredoxin-1 attenuates early graft loss after intraportal islet transplantation in mice.Application of an endothelialized modular construct for islet transplantation in syngeneic and allogeneic immunosuppressed rat models.Eicosanoids, β-cell function, and diabetesEngineered VEGF-releasing PEG-MAL hydrogel for pancreatic islet vascularization.Pro-inflammatory and pro-oxidant status of pancreatic islet in vitro is controlled by TLR-4 and HO-1 pathways.Elevation of vascular endothelial growth factor production and its effect on revascularization and function of graft islets in diabetic rats.Engineering biomimetic materials for islet transplantationImprovement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist.Anti-apoptotic Effects of Bone Marrow on Human Islets: A Preliminary Report.Nerve growth factor is associated with islet graft failure following intraportal transplantation.A theranostic small interfering RNA nanoprobe protects pancreatic islet grafts from adoptively transferred immune rejectionTreatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids.Allogeneic bone marrow cocultured with human islets significantly improves islet survival and function in vivo.Inhibition of the MAP3 kinase Tpl2 protects rodent and human β-cells from apoptosis and dysfunction induced by cytokines and enhances anti-inflammatory actions of exendin-4.Factors Influencing the Loss of β-Cell Mass in Islet Transplantation.PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes.
P2860
Q21132468-E1F8B822-550F-4429-86A9-C76886101E83Q26751467-FB554239-7801-4FDA-82B6-58A8B4601293Q26752205-669F9EFA-C789-4FE0-A685-5EB0DC21C9A1Q26851906-8C34BEBA-0448-4E4F-8402-F28C108E884CQ27010290-125E432F-7779-4564-82F8-A9CC7DDE8B3FQ28384702-5E2ECE88-DB93-4679-A75E-56AA9D2618AAQ28579977-C7D1E0AB-1EE0-433E-86A3-6E4C6912E551Q30373454-2535888B-195F-486D-B1D6-00F5A10DB83FQ30430008-1522FD06-A17D-4632-A267-A48E08C72B65Q31006569-C33303E1-ECE9-451C-8AF2-5679162C3CFCQ33614652-8C1557E6-C717-49EB-938B-E5B86499CFBCQ33758370-50C272F4-9BBB-415D-98F3-10C16821FAFCQ33759539-7B33F3AF-8A51-4510-A1CD-899D51B002D4Q33813238-189C93C9-FD42-4846-A6D3-A4CA57735881Q33857610-5F2D24A9-D036-422F-9ABA-6520E28219F3Q33890308-C76B5E50-5305-47E4-A37C-5370990A0005Q34181504-85A1A799-CA09-4AF9-A55A-4D6C6FE2497BQ34292905-AC026E73-39CB-4EDD-85AE-E9008323DBD5Q34488816-888E1A3D-1C05-4EE9-B164-026F7E9916D5Q34512289-51FD69C4-F14F-4661-BBA3-21C444FC5FACQ34527135-1E7B447F-55C8-4BCC-9D15-0A9A693F7ECBQ34603718-1E6F3F23-15F2-404D-BEBB-64C17FAA52DDQ34729434-55B73638-7036-430B-94F9-1F10794BE39FQ34744307-1CA4D6F1-B57E-403E-A946-F78C8DB217DEQ34946641-BB8F08A7-47E6-4B22-BC9A-6203E341C9B3Q35125065-B6D13B01-8DDB-4297-9EC9-BA673ED3ED35Q35129888-74D8B545-442D-4F16-8652-10E5E828B0B1Q35197394-82694BEB-1A44-4DBC-A510-A1DABE1FD671Q35364286-396F26FB-E662-4149-B95A-86C08AEC367DQ35397286-1CC27194-F709-48A6-8458-8B090400AF81Q35661081-DEB7E3ED-D403-4BA1-986F-98C8260FD20BQ35882545-31A39F8F-A493-4AFB-B233-703EB312DDCFQ35897235-C30EB3E9-7CE5-47DC-9B6F-D6EFB7C45E80Q36003185-5AD69A04-14FE-4344-B7C8-FA300E91AD9CQ36410697-164F20D7-23F6-4227-B23A-7D535740A1ADQ36538911-8212739A-B3B7-45C5-A516-C9824343AA10Q36704082-07F510BA-9E56-4E97-B758-F7ADEB334999Q36751764-4BDA1DFA-C707-4510-B59D-FB291033EEEDQ36792890-C78A6E74-1A0B-4E6C-AFC1-B9BA9B57AE28Q36801593-37937113-C07F-419F-8BD3-089A0AFAD231
P2860
Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Inflammation-mediated dysfunct ...... tions for intrahepatic grafts.
@ast
Inflammation-mediated dysfunct ...... tions for intrahepatic grafts.
@en
type
label
Inflammation-mediated dysfunct ...... tions for intrahepatic grafts.
@ast
Inflammation-mediated dysfunct ...... tions for intrahepatic grafts.
@en
prefLabel
Inflammation-mediated dysfunct ...... tions for intrahepatic grafts.
@ast
Inflammation-mediated dysfunct ...... tions for intrahepatic grafts.
@en
P2093
P356
P1476
Inflammation-mediated dysfunct ...... tions for intrahepatic grafts.
@en
P2093
John A Goss
Neal R Barshes
Samuel Wyllie
P304
P356
10.1189/JLB.1104649
P577
2005-02-22T00:00:00Z